Live Chat on The Biotech Forum sees frequent discussion of specific covered call trades. To see what covered call trades I am currently executing along with a model portfolio of attractive biotech stocks, just initiate your free trial into The Biotech Forum by clicking HERE .Shares of respiratory disease concern Savara, Inc. ( SVRA ) have rebounded over 100% since receiving a refuse-to-file letter from the FDA for its sole clinical candidate (molgramostim) in May 2025. The rebound is largely due to the comp ...